CancerCell News
Bioelectric Therapy and Cancer TreatmentLeonhardt Ventures LLC Issued Pioneering Patent for Bioelectric Inflammation Treatment Device and Method
Irvine, California, United States - 09/07/2021 — Patent protects methods and devices for customized real time treatment of chronic inflammation related disorders with bioelectric stimulation based protein expressions and control Irvine, California —(PRDistribution)-...
read moreCancerCell a Leonhardt’s Launchpads Startup Announces Filing of Patent Application for a Novel Bioelectric OPG Treatment Technology for Multiple Myeloma and Other Cancers
May Also by Useful in Treating Osteoporosis by startup OrthoStim July 2nd, 2020 IRVINE, CALIFORNIA –(PR Distribution)- CancerCell www.cancercellinc.com, a biotechnology LTP stage startup within the Leonhardt’s Launchpads innovation and startup launch accelerator(s),...
read moreLeonhardt’s Launchpads Announces Issuance of New U.S. Patent for Bioelectric Plus Biologics Platform for Organ Regeneration and Healing
Latest Patent Further Strengthens Intellectual Property Portfolio Covering Novel Platform for Precisely Controlling Regenerative Protein Expressions Including Stem Cell Homing and Differentiation Control Technology Has Key Potential Applications in Regeneration of...
read moreLeonhardt’s Launchpads Accelerator To Showcase Eight Innovation Assets and Startups At 2022 Demo Day
Showcased technologies include a novel circulatory assist pump for heart failure and bioelectric and biologic treatments for erectile dysfunction, skin and hair regeneration, and rapid straightening and stabilization of teeth during orthodontic treatment. NEWS...
read moreLeonhardt Ventures Announces Issuance of Pioneering U.S. Patent for Multi-Modality Customized Bioelectric Treatment of Cancer
Published: Dec 22, 2021 Mission Viejo, California, United States, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Leonhardt Ventures LLC, a pioneer in developing bioelectric and biologic innovations for organ regeneration and healing, today announced that the U.S. Patent and...
read moreList of the issued cancer patents
9,707,403 Rapid destruction of malignant tumors by excitotoxicity and osmotic-shock medical tactics 9,636,507 Rapid destruction of malignant tumors by excitotoxicity and osmotic-shock medical tactics 9,492,478 Encoded bioelectronic method and system and calcium...
read moreLeonhardt Ventures to Enter Into Worldwide Strategic Collaboration With Neuro Code Tech Holdings for Customized Bioelectric Cancer Treatments
Salt Lake City, Utah and Albuquerque, New Mexico, January 23rd, 2017/PRBuzz: BREAKTHROUGH PATENTED AND PATENT PENDING EARLY STAGE TECHNOLOGIES ARE DESIGNED TO DETECT EARLY TUMORS VIA FAINT BIOELECTRIC SIGNALS AND READ HOW A TUMOR IS COMMUNICATING WITH ITSELF AND...
read moreLeonhardt Startup CancerCell Expands IP Estate for Bioelectric Treatment of Cancer Tumors
Published: Oct 20, 2017 First bioelectric cancer tumor therapy designed for early detection, personalized real time reading, customized communication jamming, stopping cell division, starving blood supply, changing surface protein expression to trigger immunotherapy,...
read more